Only for premium:
Start your 14-day free trial
| Download example PDF report
You have 3 of 3 checks left today.
Show your SEO score to your visitors using the Seobility widget. The widget always displays the current SEO score of your homepage.
Name | Value |
---|---|
viewport | width=device-width, initial-scale=1.0 |
robots | index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1 |
description | Onco'Zine is part of the Oncology and Hematology News Network that has been created to better inform physicians treating patients with cancer |
msvalidate.01 | 325DBF0B4415B7D5F77949B32086EEB2 |
google-site-verification | DvS50_-wX_jjHKRtegP7b3R6lPTOcwGV7N7mm1J2oAk |
generator | WordPress 6.5.5 |
msapplication-TileImage | https://www.oncozine.com/wp-content/uploads/2018/09/cropped-circle-270x270.png |
article:publisher | https://www.facebook.com/oncozine.journal |
article:modified_time | 2023-11-14T01:28:40+00:00 |
lang | en-us |
twitter:card | summary_large_image |
twitter:site | @OncoZine |
fb:pages | https://www.facebook.com/OncoZine/ |
og:locale | en_US |
og:type | website |
og:title | Home - Onco'Zine - A part of the Oncology and Hematology News Network |
og:description | Onco'Zine is part of the Oncology and Hematology News Network that has been created to better inform physicians treating patients with cancer |
og:url | https://www.oncozine.com/ |
og:site_name | Onco'Zine |
charset | UTF-8 |
URL | Alt attribute | Title |
---|---|---|
...tent/uploads/2019/06/oncozine_270x90.png | OncoZine, The International On | OncoZine, The International Oncology Network |
.../uploads/2019/06/oncozine-140x48_wht.png | OncoZine, The International On | OncoZine, The International Oncology Network |
...tent/uploads/2019/06/oncozine_270x90.png | OncoZine, The International On | OncoZine, The International Oncology Network |
...ads/2020/02/oncozine_brief-300x250-1.png | spot_img | |
...F4D-4F06-AB10-E80D755FFC56_4_5005_c.jpeg | spot_img | |
...ers-of-the-Cancer-Universe-300x250-1.jpg | spot_img | |
.../uploads/2019/06/oncozine_270x90_wht.png | Onco\ | Onco\'Zine, The International Oncology Network |
...nt/uploads/2021/05/subcription-popup.png | No alt attribute provided |
Heading level | Content |
---|---|
H1 | Onco'Zine OncoZine, The International Oncology Network |
H3 | Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials |
H3 | Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show |
H3 | Study Shows New Co-Star Receptor to be Promising in Cancer Treatment |
H3 | The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many |
H3 | ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011 |
H3 | Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials Duplicate text |
H3 | Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show Duplicate text |
H3 | The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many Duplicate text |
H3 | The Transformative Potential of Exosome Research in Cancer Detection and Beyond |
H3 | A Global View of Oncology Informatics |
H3 | Standardizing Immunophenotyping Research Tools to Improve MDS and the Immune System |
H3 | Experts Forecast: Achieving Cancer Health Equity |
H3 | The Impact of DCISionRT Versus Clinicopathologic Factors Alone in Predicting Benefit of Radiation |
H3 | Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials Duplicate text |
H3 | Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show Duplicate text |
H3 | Study Shows New Co-Star Receptor to be Promising in Cancer Treatment Duplicate text |
H3 | The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many Duplicate text |
H3 | ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011 Duplicate text |
H3 | ASCO 2024: Adagrasib Shows Statistically Significant Improvement in PFS in KRASG12C-Mutated NSCLC |
H3 | ASCO 2024: A More Effective Treatment Combination for Hodgkin Lymphoma |
H3 | ASCO 2024: Asciminib – A Safer + More Effective Option for Newly Diagnosed Chronic... |
H3 | ASCO 2024: Durable Efficacy of Lorlatinib as a first-line choice in ALK-positive NSCLC n |
H3 | ASCO 2024: NATALEE shows Ribociclib Reduces Risk of Cancer Recurrence in Early Breast Cancer |
H3 | ASCO 2024: AbbVie to Showcases Robust Solid Tumor Pipeline with New Data from Its... |
H3 | Strong Immunology Portfolio helps Offset losses of AbbVie’s Adalimumab |
H3 | ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011 Duplicate text |
H3 | ASCO 2024: Adagrasib Shows Statistically Significant Improvement in PFS in KRASG12C-Mutated NSCLC Duplicate text |
H3 | ASCO 2024: A More Effective Treatment Combination for Hodgkin Lymphoma Duplicate text |
H3 | ASCO 2024: Asciminib – A Safer + More Effective Option for Newly Diagnosed Chronic... Duplicate text |
H3 | ASCO 2024: Durable Efficacy of Lorlatinib as a first-line choice in ALK-positive NSCLC n Duplicate text |
H3 | ASCO 2024: NATALEE shows Ribociclib Reduces Risk of Cancer Recurrence in Early Breast Cancer Duplicate text |
H3 | ASCO 2024: AbbVie to Showcases Robust Solid Tumor Pipeline with New Data from Its... Duplicate text |
H3 | ASCO 2024: Bristol Myers Squibb to Present Results from 130 Studies |
H3 | Encouraging Conversation & Action on Sexual Health and Fertility for Patients Diagnosed with Cancer |
H3 | Increased Overall Survival Reported for Combination of Durvalumab plus Chemotherapy |
H3 | Study Shows Positive Results in Treatment of Cervical High-Grade Squamous Intraepithelial Lesion |
H3 | Immunotherapy After Surgery Improves Survival in Patients with Kidney Cancer |
H3 | A Global View of Oncology Informatics Duplicate text |
H3 | Standardizing Immunophenotyping Research Tools to Improve MDS and the Immune System Duplicate text |
H3 | Experts Forecast: Achieving Cancer Health Equity Duplicate text |
H3 | The Impact of DCISionRT Versus Clinicopathologic Factors Alone in Predicting Benefit of Radiation Duplicate text |
H3 | Forecast 2024: Broadening the Reach of Cancer Vaccines |
H3 | The Digital Frontier: 5 Ways Oncology Informatics is Enhancing Cancer Care |
H3 | Remembering Emil “Jay” Freireich—the Man Who Made Vince DeVita a ‘Believer’ |
H3 | Why Were Top HHS Officials? Interviews Thwarted by Their Press Offices? |
H3 | Jason Moore, PhD: Improving the Lives of Patients through Computing Technologies and Data Resources |
H3 | SonALAsense: Developing a Safe and Effective Noninvasive Treatment for Cancer |
H3 | Be The Match®: Improving Outcomes and Providing Hope to Patients in Need |
H3 | Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials Duplicate text |
H3 | Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show Duplicate text |
H3 | Study Shows New Co-Star Receptor to be Promising in Cancer Treatment Duplicate text |
H3 | Daiichi Sankyo Out-Licenses Investigational Agent DS-6051 to AnHeart Therapeutics |
H3 | How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s Fall? |
H3 | Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’... |
H4 | FEATURED |
H4 | NEWS |
H4 | CONFERENCE COVERAGE |
H4 | EDITORIAL |
H4 | ERIC ROSENTHAL REPORTS |
H4 | EXPERT INTERVIEWS |
Link | Attributes | Anchor text |
---|---|---|
https://www.facebook.com/oncoz... | New window External Subdomain | A-TITLE Facebook |
https://www.linkedin.com/showc... | New window External Subdomain | A-TITLE Linkedin |
https://soundcloud.com/hofrey | New window External | A-TITLE Soundcloud |
https://twitter.com/OncoZine | New window External | A-TITLE Twitter |
https://vimeo.com/channels/877242 | New window External | A-TITLE Vimeo |
https://www.youtube.com/channe... | New window External Subdomain | A-TITLE Youtube |
https://www.xing.com/communiti... | New window External Subdomain | A-TITLE Xing |
https://www.oncozine.com/ | Subdomain | Home |
/advertisement-sponsorship-opt... | Subdomain | Advertisement & Sponsorship Options |
https://lp.constantcontactpage... | External Subdomain | Download Our Media Kit |
/continued-medical-education-cme/ | Subdomain | Changing Physician Behavior |
/cancer-information-by-disease/ | Subdomain | Cancer A – Z |
http://www.oncozine.com/ | Subdomain | Drug Developmemt Technologies |
/a-novel-technology-based-on-s... | Subdomain | A Novel Technology based on Somatic Hypermutation (SHM) |
/about-oncozine/advisory-board-3/ | Subdomain | Editorial Advisory Board |
/join-our-editorial-advisory-b... | Subdomain | Join Our Editorial Advisory Board |
/contact-us/ | Subdomain | Contact Us |
/terms-and-conditions/ | Subdomain | Terms and Conditions |
/sabcs-and-ash-2023/ | Subdomain | SABCS and ASH 2023 |
http://www.adcreview.com/ | External Subdomain | ADC Review | J. Antibody-drug Conjugates |
https://www.adcreview.com/reso... | External Subdomain | Resources for For Clinicians |
https://www.adcreview.com/adc-... | External Subdomain | Drug Map (ADC) |
https://www.adcreview.com/cate... | External Subdomain | Peer Review Articles |
https://www.adcreview.com/the-... | External Subdomain | The Review |
/changing-strategies-in-the-wa... | Subdomain | Changing Strategies in the War on Cancer |
/changing-strategies-in-the-wa... | Subdomain | Changing Strategies in the War on Cancer – Episode 1 |
/changing-strategies-in-the-wa... | Subdomain | Changing Strategies in the War on Cancer – Episode 2 |
/changing-strategies-in-the-wa... | Subdomain | Changing Strategies in the War on Cancer – Episode 3 |
/centers-of-the-cancer-univers... | Subdomain | Centers of the Cancer Universe: A Half-Century of Progress Against Cancer |
http://cartcelljournal.com/ | External | Journal of CAR T-Cell Therapy |
http://cartcelljournal.com/about/ | External | About CAR T-cells |
http://cartcelljournal.com/faq/ | External | Frequently Asked Questions |
http://cartcelljournal.com/art... | External | Types of Articles |
http://cartcelljournal.com/for... | External | Submit a Manuscript |
/the_oncozine_brief_episodes/ | Subdomain | The Onco’Zine Brief |
/the_oncozine_brief_episodes/ | Subdomain | The Network |
/the-oncozine-brief-episodes/ | Subdomain | The Episodes |
https://www.patreon.com/theonc... | New window External Subdomain | How to Support The Onco’Zine Brief |
/underwriting/ | Subdomain | Corporate Underwriting and Sponsorship |
/the-oncozine-dossier/ | Subdomain | The Onco’Zine Dossier |
/thalidomide-a-history/ | Subdomain | Thalidomide: A History |
/thalidomide-in-the-shadow-of-... | Subdomain | Thalidomide: In the Shadow of Death |
/controversy-the-involvement-o... | Subdomain | Controversy: The involvement of Ciba AG in the development of Thalidomide |
/thalidomides-secret-past-the-... | Subdomain | Thalidomide’s Secret Past: The Link with Nazi Germany |
/reversal-of-fortune-how-a-vil... | Subdomain | Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer |
/oncozine-dossier-50-years-aft... | Subdomain | Smoking and Health |
/new-surgeon-generals-report-p... | Subdomain | New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco |
/smoking-and-the-lost-legacy-o... | Subdomain | Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health |
/tobacco-control-in-the-united... | Subdomain | Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years |
http://.com/tobacco-companies-... | External | Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking |
/the-harmful-effects-of-smokin... | Subdomain | The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s |
/oncozine.com/oncology-hematol... | Subdomain | Drug Approvals 2017 – 2020 |
/oncology-hematology-drug-appr... | Subdomain | Oncology & Hematology – FDA Drug Approvals 2018 |
/oncology-hematology-fda-drug-... | Subdomain | Oncology & Hematology – FDA Drug Approvals 2019 |
/oncology-hematology-fda-drug-... | Subdomain | Oncology & Hematology – FDA Drug Approvals 2020 |
/category/articles/ | Subdomain | Articles |
/category/latest-articles/ | Subdomain | Latest Articles |
/category/expert-interviews/ | Subdomain | Expert Interviews |
/category/editorial-and-commen... | Subdomain | Editorials and Commentaries |
/category/eric-rosenthal-reports/ | Subdomain | Eric Rosenthal Reports |
/category/publications-peer-re... | Subdomain | Publications |
/category/news/ | Subdomain | News |
/category/business-economics/ | Subdomain | Business & Economics |
/category/clinical-development/ | Subdomain | Clinical Development |
/category/conference-coverage/ | Subdomain | Conference Coverage |
/the_oncozine_brief_episodes/ | Subdomain Text duplicate | The Onco’Zine Brief |
/the-oncozine-brief-episodes/ | Subdomain Text duplicate | The Episodes |
/the-oncozine-brief-national-a... | Subdomain | National Advertising |
http://www.oncozine.com/ | New window Subdomain | Resources |
https://www.oncologydirectory.... | New window External Subdomain | Membership |
https://www.oncologydirectory.... | External Subdomain | Agenda |
https://www.oncologydirectory.... | New window External Subdomain | Join Today |
https://www.oncologydirectory.... | New window External Subdomain | Video |
/job-openings/ | Subdomain | Careers |
/about-oncozine/about-oncozine-2/ | Subdomain | About |
/about-oncozine/advertise-with... | Subdomain | Advertise |
/about-oncozine/advisory-board... | Subdomain | Advisory Board |
/contact-us/ | Subdomain Text duplicate | Contact Us |
https://www.facebook.com/oncoz... | New window External Subdomain Text duplicate | A-TITLE Facebook |
https://www.linkedin.com/showc... | New window External Subdomain Text duplicate | A-TITLE Linkedin |
https://soundcloud.com/hofrey | New window External Text duplicate | A-TITLE Soundcloud |
https://twitter.com/OncoZine | New window External Text duplicate | A-TITLE Twitter |
https://vimeo.com/channels/877242 | New window External Text duplicate | A-TITLE Vimeo |
https://www.youtube.com/channe... | New window External Subdomain Text duplicate | A-TITLE Youtube |
https://www.xing.com/communiti... | New window External Subdomain Text duplicate | A-TITLE Xing |
https://www.oncozine.com/ | Subdomain | Onco'Zine IMG-ALT OncoZine, The International Oncology Network |
https://www.oncozine.com/ | Subdomain | IMG-ALT OncoZine, The International Oncology Network |
https://www.oncozine.com/ | Subdomain Text duplicate | IMG-ALT OncoZine, The International Oncology Network |
https://www.oncozine.com/ | Subdomain Text duplicate | Home |
/advertisement-sponsorship-opt... | Subdomain Text duplicate | Advertisement & Sponsorship Options |
https://lp.constantcontactpage... | External Subdomain Text duplicate | Download Our Media Kit |
/continued-medical-education-cme/ | Subdomain Text duplicate | Changing Physician Behavior |
/cancer-information-by-disease/ | Subdomain Text duplicate | Cancer A – Z |
http://www.oncozine.com/ | Subdomain Text duplicate | Drug Developmemt Technologies |
/a-novel-technology-based-on-s... | Subdomain Text duplicate | A Novel Technology based on Somatic Hypermutation (SHM) |
/about-oncozine/advisory-board-3/ | Subdomain Text duplicate | Editorial Advisory Board |
/join-our-editorial-advisory-b... | Subdomain Text duplicate | Join Our Editorial Advisory Board |
/contact-us/ | Subdomain Text duplicate | Contact Us |
/terms-and-conditions/ | Subdomain Text duplicate | Terms and Conditions |
/sabcs-and-ash-2023/ | Subdomain Text duplicate | SABCS and ASH 2023 |
http://www.adcreview.com/ | External Subdomain Text duplicate | ADC Review | J. Antibody-drug Conjugates |
https://www.adcreview.com/reso... | External Subdomain Text duplicate | Resources for For Clinicians |
https://www.adcreview.com/adc-... | External Subdomain Text duplicate | Drug Map (ADC) |
https://www.adcreview.com/cate... | External Subdomain Text duplicate | Peer Review Articles |
https://www.adcreview.com/the-... | External Subdomain Text duplicate | The Review |
/changing-strategies-in-the-wa... | Subdomain Text duplicate | Changing Strategies in the War on Cancer |
/changing-strategies-in-the-wa... | Subdomain Text duplicate | Changing Strategies in the War on Cancer – Episode 1 |
/changing-strategies-in-the-wa... | Subdomain Text duplicate | Changing Strategies in the War on Cancer – Episode 2 |
/changing-strategies-in-the-wa... | Subdomain Text duplicate | Changing Strategies in the War on Cancer – Episode 3 |
/centers-of-the-cancer-univers... | Subdomain Text duplicate | Centers of the Cancer Universe: A Half-Century of Progress Against Cancer |
http://cartcelljournal.com/ | External Text duplicate | Journal of CAR T-Cell Therapy |
http://cartcelljournal.com/about/ | External Text duplicate | About CAR T-cells |
http://cartcelljournal.com/faq/ | External Text duplicate | Frequently Asked Questions |
http://cartcelljournal.com/art... | External Text duplicate | Types of Articles |
http://cartcelljournal.com/for... | External Text duplicate | Submit a Manuscript |
/the_oncozine_brief_episodes/ | Subdomain Text duplicate | The Onco’Zine Brief |
/the_oncozine_brief_episodes/ | Subdomain Text duplicate | The Network |
/the-oncozine-brief-episodes/ | Subdomain Text duplicate | The Episodes |
https://www.patreon.com/theonc... | New window External Subdomain Text duplicate | How to Support The Onco’Zine Brief |
/underwriting/ | Subdomain Text duplicate | Corporate Underwriting and Sponsorship |
/the-oncozine-dossier/ | Subdomain Text duplicate | The Onco’Zine Dossier |
/thalidomide-a-history/ | Subdomain Text duplicate | Thalidomide: A History |
/thalidomide-in-the-shadow-of-... | Subdomain Text duplicate | Thalidomide: In the Shadow of Death |
/controversy-the-involvement-o... | Subdomain Text duplicate | Controversy: The involvement of Ciba AG in the development of Thalidomide |
/thalidomides-secret-past-the-... | Subdomain Text duplicate | Thalidomide’s Secret Past: The Link with Nazi Germany |
/reversal-of-fortune-how-a-vil... | Subdomain Text duplicate | Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer |
/oncozine-dossier-50-years-aft... | Subdomain Text duplicate | Smoking and Health |
/new-surgeon-generals-report-p... | Subdomain Text duplicate | New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco |
/smoking-and-the-lost-legacy-o... | Subdomain Text duplicate | Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health |
/tobacco-control-in-the-united... | Subdomain Text duplicate | Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years |
http://.com/tobacco-companies-... | External Text duplicate | Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking |
/the-harmful-effects-of-smokin... | Subdomain Text duplicate | The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s |
/oncozine.com/oncology-hematol... | Subdomain Text duplicate | Drug Approvals 2017 – 2020 |
/oncology-hematology-drug-appr... | Subdomain Text duplicate | Oncology & Hematology – FDA Drug Approvals 2018 |
/oncology-hematology-fda-drug-... | Subdomain Text duplicate | Oncology & Hematology – FDA Drug Approvals 2019 |
/oncology-hematology-fda-drug-... | Subdomain Text duplicate | Oncology & Hematology – FDA Drug Approvals 2020 |
/category/articles/ | Subdomain Text duplicate | Articles |
/category/latest-articles/ | Subdomain Text duplicate | Latest Articles |
/category/expert-interviews/ | Subdomain Text duplicate | Expert Interviews |
/category/editorial-and-commen... | Subdomain Text duplicate | Editorials and Commentaries |
/category/eric-rosenthal-reports/ | Subdomain Text duplicate | Eric Rosenthal Reports |
/category/publications-peer-re... | Subdomain Text duplicate | Publications |
/category/news/ | Subdomain Text duplicate | News |
/category/business-economics/ | Subdomain Text duplicate | Business & Economics |
/category/clinical-development/ | Subdomain Text duplicate | Clinical Development |
/category/conference-coverage/ | Subdomain Text duplicate | Conference Coverage |
/the_oncozine_brief_episodes/ | Subdomain Text duplicate | The Onco’Zine Brief |
/the-oncozine-brief-episodes/ | Subdomain Text duplicate | The Episodes |
/the-oncozine-brief-national-a... | Subdomain Text duplicate | National Advertising |
http://www.oncozine.com/ | New window Subdomain Text duplicate | Resources |
https://www.oncologydirectory.... | New window External Subdomain Text duplicate | Membership |
https://www.oncologydirectory.... | External Subdomain Text duplicate | Agenda |
https://www.oncologydirectory.... | New window External Subdomain Text duplicate | Join Today |
https://www.oncologydirectory.... | New window External Subdomain Text duplicate | Video |
/job-openings/ | Subdomain Text duplicate | Careers |
/solutions-to-identify-patient... | Subdomain | A-TITLE Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials |
/solutions-to-identify-patient... | Subdomain Text duplicate | Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials A-TITLE Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials |
/author/kimberly_futch_001_bs-... | Subdomain | Kimberly Futch |
/crofelemer-reduces-diarrhea-i... | Subdomain | A-TITLE Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show |
/crofelemer-reduces-diarrhea-i... | Subdomain Text duplicate | Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show A-TITLE Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show |
/study-shows-new-co-star-recep... | Subdomain | A-TITLE Study Shows New Co-Star Receptor to be Promising in Cancer Treatment |
/study-shows-new-co-star-recep... | Subdomain Text duplicate | Study Shows New Co-Star Receptor to be Promising in Cancer Treatment A-TITLE Study Shows New Co-Star Receptor to be Promising in Cancer Treatment |
/the-concierge-catch-better-ac... | Subdomain | A-TITLE The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many |
/the-concierge-catch-better-ac... | Subdomain Text duplicate | The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many A-TITLE The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many |
/asco-2024-encouraging-dose-es... | Subdomain | A-TITLE ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011 |
/asco-2024-encouraging-dose-es... | Subdomain Text duplicate | ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011 A-TITLE ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011 |
/category/featured/ | Subdomain | FEATURED |
/solutions-to-identify-patient... | Subdomain Text duplicate | Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials A-TITLE Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials |
/author/kimberly_futch_001_bs-... | Subdomain Text duplicate | Kimberly Futch |
/crofelemer-reduces-diarrhea-i... | Subdomain Text duplicate | Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show A-TITLE Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show |
/author/okhuysen_pc-001/ | Subdomain | Pablo C. Okhuysen, M.D., FACP, FIDSA |
/the-concierge-catch-better-ac... | Subdomain Text duplicate | The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many A-TITLE The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many |
/author/john-rossheim_001a/ | Subdomain | John Rossheim |
/the-transformative-potential-... | Subdomain | The Transformative Potential of Exosome Research in Cancer Detection and Beyond A-TITLE The Transformative Potential of Exosome Research in Cancer Detection and Beyond |
/author/biological_d-hdhani_001/ | Subdomain | Harmeet Dhani, MD, MSc |
/a-global-view-of-oncology-inf... | Subdomain | A Global View of Oncology Informatics A-TITLE A Global View of Oncology Informatics |
/author/maria_dolores-mata-moy... | Subdomain | María Dolores de la Mata Moya |
/standardizing-immunophenotypi... | Subdomain | Standardizing Immunophenotyping Research Tools to Improve MDS and the Immune System A-TITLE Standardizing Immunophenotyping Research Tools to Improve MDS and the Immune System |
/author/leonardo_beretta_001-ad/ | Subdomain | Leonardo Beretta |
/experts-forecast-achieving-ca... | Subdomain | Experts Forecast: Achieving Cancer Health Equity A-TITLE Experts Forecast: Achieving Cancer Health Equity |
/author/neha_j_pancholi_001/ | Subdomain | Neha J. Pancholi, PhD |
/the-impact-of-dcisionrt-versu... | Subdomain | The Impact of DCISionRT Versus Clinicopathologic Factors Alone in Predicting Benefit of Radiation A-TITLE The Impact of DCISionRT Versus Clinicopathologic Factors Alone in Predicting Benefit of Radiation |
/author/amishi-bajaj-001/ | Subdomain | Amishi Bajaj, MD |
/category/news | Subdomain | NEWS |
/solutions-to-identify-patient... | Subdomain Text duplicate | Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials A-TITLE Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials |
/author/kimberly_futch_001_bs-... | Subdomain Text duplicate | Kimberly Futch |
/crofelemer-reduces-diarrhea-i... | Subdomain Text duplicate | Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show A-TITLE Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show |
/author/okhuysen_pc-001/ | Subdomain Text duplicate | Pablo C. Okhuysen, M.D., FACP, FIDSA |
/study-shows-new-co-star-recep... | Subdomain Text duplicate | Study Shows New Co-Star Receptor to be Promising in Cancer Treatment A-TITLE Study Shows New Co-Star Receptor to be Promising in Cancer Treatment |
/author/peter-hofland/ | Subdomain | Peter Hofland |
/the-concierge-catch-better-ac... | Subdomain Text duplicate | The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many A-TITLE The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many |
/author/john-rossheim_001a/ | Subdomain Text duplicate | John Rossheim |
/asco-2024-encouraging-dose-es... | Subdomain Text duplicate | ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011 A-TITLE ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011 |
/author/editorial_team/ | Subdomain | Editorial Team |
/asco-2024-adagrasib-shows-sta... | Subdomain | ASCO 2024: Adagrasib Shows Statistically Significant Improvement in PFS in KRASG12C-Mutated NSCLC A-TITLE ASCO 2024: Adagrasib Shows Statistically Significant Improvement in PFS in KRASG12C-Mutated NSCLC |
/author/editorial_team/ | Subdomain Text duplicate | Editorial Team |
/asco-2024-a-more-effective-tr... | Subdomain | ASCO 2024: A More Effective Treatment Combination for Hodgkin Lymphoma A-TITLE ASCO 2024: A More Effective Treatment Combination for Hodgkin Lymphoma |
/author/editorial_team/ | Subdomain Text duplicate | Editorial Team |
/asco-2024-asciminib-a-safer-m... | Subdomain | ASCO 2024: Asciminib – A Safer + More Effective Option for Newly Diagnosed Chronic... A-TITLE ASCO 2024: Asciminib – A Safer + More Effective Option for Newly Diagnosed Chronic Myeloid Leukemia |
/author/editorial_team/ | Subdomain Text duplicate | Editorial Team |
/asco-2024-durable-efficacy-of... | Subdomain | ASCO 2024: Durable Efficacy of Lorlatinib as a first-line choice in ALK-positive NSCLC n A-TITLE ASCO 2024: Durable Efficacy of Lorlatinib as a first-line choice in ALK-positive NSCLC n |
/author/editorial_team/ | Subdomain Text duplicate | Editorial Team |
/asco-2024-natalee-shows-riboc... | Subdomain | ASCO 2024: NATALEE shows Ribociclib Reduces Risk of Cancer Recurrence in Early Breast Cancer A-TITLE ASCO 2024: NATALEE shows Ribociclib Reduces Risk of Cancer Recurrence in Early Breast Cancer |
/author/editorial_team/ | Subdomain Text duplicate | Editorial Team |
/asco-2024-abbvie-to-showcases... | Subdomain | ASCO 2024: AbbVie to Showcases Robust Solid Tumor Pipeline with New Data from Its... A-TITLE ASCO 2024: AbbVie to Showcases Robust Solid Tumor Pipeline with New Data from Its ADC Platform |
/author/editorial_team/ | Subdomain Text duplicate | Editorial Team |
/strong-immunology-portfolio-h... | Subdomain | Strong Immunology Portfolio helps Offset losses of AbbVie’s Adalimumab A-TITLE Strong Immunology Portfolio helps Offset losses of AbbVie’s Adalimumab |
/author/editorial_team/ | Subdomain Text duplicate | Editorial Team |
/asco-2024-encouraging-dose-es... | Subdomain Text duplicate | ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011 A-TITLE ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011 |
/author/editorial_team/ | Subdomain Text duplicate | Editorial Team |
/asco-2024-adagrasib-shows-sta... | Subdomain Text duplicate | ASCO 2024: Adagrasib Shows Statistically Significant Improvement in PFS in KRASG12C-Mutated NSCLC A-TITLE ASCO 2024: Adagrasib Shows Statistically Significant Improvement in PFS in KRASG12C-Mutated NSCLC |
/author/editorial_team/ | Subdomain Text duplicate | Editorial Team |
/asco-2024-a-more-effective-tr... | Subdomain Text duplicate | ASCO 2024: A More Effective Treatment Combination for Hodgkin Lymphoma A-TITLE ASCO 2024: A More Effective Treatment Combination for Hodgkin Lymphoma |
/author/editorial_team/ | Subdomain Text duplicate | Editorial Team |
/asco-2024-asciminib-a-safer-m... | Subdomain Text duplicate | ASCO 2024: Asciminib – A Safer + More Effective Option for Newly Diagnosed Chronic... A-TITLE ASCO 2024: Asciminib – A Safer + More Effective Option for Newly Diagnosed Chronic Myeloid Leukemia |
/author/editorial_team/ | Subdomain Text duplicate | Editorial Team |
/asco-2024-durable-efficacy-of... | Subdomain Text duplicate | ASCO 2024: Durable Efficacy of Lorlatinib as a first-line choice in ALK-positive NSCLC n A-TITLE ASCO 2024: Durable Efficacy of Lorlatinib as a first-line choice in ALK-positive NSCLC n |
/author/editorial_team/ | Subdomain Text duplicate | Editorial Team |
/asco-2024-natalee-shows-riboc... | Subdomain Text duplicate | ASCO 2024: NATALEE shows Ribociclib Reduces Risk of Cancer Recurrence in Early Breast Cancer A-TITLE ASCO 2024: NATALEE shows Ribociclib Reduces Risk of Cancer Recurrence in Early Breast Cancer |
/author/editorial_team/ | Subdomain Text duplicate | Editorial Team |
/asco-2024-abbvie-to-showcases... | Subdomain Text duplicate | ASCO 2024: AbbVie to Showcases Robust Solid Tumor Pipeline with New Data from Its... A-TITLE ASCO 2024: AbbVie to Showcases Robust Solid Tumor Pipeline with New Data from Its ADC Platform |
/author/editorial_team/ | Subdomain Text duplicate | Editorial Team |
/asco-2024-bristol-myers-squib... | Subdomain | ASCO 2024: Bristol Myers Squibb to Present Results from 130 Studies A-TITLE ASCO 2024: Bristol Myers Squibb to Present Results from 130 Studies |
/author/editorial_team/ | Subdomain Text duplicate | Editorial Team |
/encouraging-conversation-acti... | Subdomain | Encouraging Conversation & Action on Sexual Health and Fertility for Patients Diagnosed with Cancer A-TITLE Encouraging Conversation & Action on Sexual Health and Fertility for Patients Diagnosed with Cancer |
/author/editorial_team/ | Subdomain Text duplicate | Editorial Team |
/increased-overall-survival-re... | Subdomain | Increased Overall Survival Reported for Combination of Durvalumab plus Chemotherapy A-TITLE Increased Overall Survival Reported for Combination of Durvalumab plus Chemotherapy |
/author/peter-hofland/ | Subdomain Text duplicate | Peter Hofland |
/study-shows-positive-results-... | Subdomain | Study Shows Positive Results in Treatment of Cervical High-Grade Squamous Intraepithelial Lesion A-TITLE Study Shows Positive Results in Treatment of Cervical High-Grade Squamous Intraepithelial Lesion |
/author/editorial_team/ | Subdomain Text duplicate | Editorial Team |
/immunotherapy-after-surgery-i... | Subdomain | Immunotherapy After Surgery Improves Survival in Patients with Kidney Cancer A-TITLE Immunotherapy After Surgery Improves Survival in Patients with Kidney Cancer |
/author/editorial_team/ | Subdomain Text duplicate | Editorial Team |
/category/editorial/ | Subdomain | EDITORIAL |
/a-global-view-of-oncology-inf... | Subdomain Text duplicate | A Global View of Oncology Informatics A-TITLE A Global View of Oncology Informatics |
/author/maria_dolores-mata-moy... | Subdomain Text duplicate | María Dolores de la Mata Moya |
/standardizing-immunophenotypi... | Subdomain Text duplicate | Standardizing Immunophenotyping Research Tools to Improve MDS and the Immune System A-TITLE Standardizing Immunophenotyping Research Tools to Improve MDS and the Immune System |
/author/leonardo_beretta_001-ad/ | Subdomain Text duplicate | Leonardo Beretta |
/experts-forecast-achieving-ca... | Subdomain Text duplicate | Experts Forecast: Achieving Cancer Health Equity A-TITLE Experts Forecast: Achieving Cancer Health Equity |
/author/neha_j_pancholi_001/ | Subdomain Text duplicate | Neha J. Pancholi, PhD |
/the-impact-of-dcisionrt-versu... | Subdomain Text duplicate | The Impact of DCISionRT Versus Clinicopathologic Factors Alone in Predicting Benefit of Radiation A-TITLE The Impact of DCISionRT Versus Clinicopathologic Factors Alone in Predicting Benefit of Radiation |
/author/amishi-bajaj-001/ | Subdomain Text duplicate | Amishi Bajaj, MD |
/forecast-2024-broadening-the-... | Subdomain | Forecast 2024: Broadening the Reach of Cancer Vaccines A-TITLE Forecast 2024: Broadening the Reach of Cancer Vaccines |
/author/neha_j_pancholi_001/ | Subdomain Text duplicate | Neha J. Pancholi, PhD |
/the-digital-frontier-5-ways-o... | Subdomain | The Digital Frontier: 5 Ways Oncology Informatics is Enhancing Cancer Care A-TITLE The Digital Frontier: 5 Ways Oncology Informatics is Enhancing Cancer Care |
/author/jesse-kaestner-001/ | Subdomain | Jesse Kaestner |
/category/eric-rosenthal-reports/ | Subdomain | ERIC ROSENTHAL REPORTS |
/remembering-emil-jay-freireic... | Subdomain | Remembering Emil “Jay” Freireich—the Man Who Made Vince DeVita a ‘Believer’ A-TITLE Remembering Emil “Jay” Freireich—the Man Who Made Vince DeVita a ‘Believer’ |
/author/erictrosenthal/ | Subdomain | Eric T. Rosenthal |
/why-were-top-hhs-officials-in... | Subdomain | Why Were Top HHS Officials? Interviews Thwarted by Their Press Offices? A-TITLE Why Were Top HHS Officials? Interviews Thwarted by Their Press Offices? |
/author/erictrosenthal/ | Subdomain Text duplicate | Eric T. Rosenthal |
/category/expert-interviews/ | Subdomain | EXPERT INTERVIEWS |
/jason-moore-phd-improving-the... | Subdomain | Jason Moore, PhD: Improving the Lives of Patients through Computing Technologies and Data Resources A-TITLE Jason Moore, PhD: Improving the Lives of Patients through Computing Technologies and Data Resources |
/author/editorial_team/ | Subdomain Text duplicate | Editorial Team |
/sonalasense-developing-a-safe... | Subdomain | SonALAsense: Developing a Safe and Effective Noninvasive Treatment for Cancer A-TITLE SonALAsense: Developing a Safe and Effective Noninvasive Treatment for Cancer |
/author/danielle_garcia/ | Subdomain | Danielle Garcia |
/be-the-match-improving-outcom... | Subdomain | Be The Match®: Improving Outcomes and Providing Hope to Patients in Need A-TITLE Be The Match®: Improving Outcomes and Providing Hope to Patients in Need |
/author/danielle_garcia/ | Subdomain Text duplicate | Danielle Garcia |
/the-oncozine-brief-episodes/ | Subdomain | IMG-ALT spot_img |
https://amzn.to/378W1I6 | External Text duplicate | IMG-ALT spot_img |
https://amzn.to/3Z0DFEU | External Text duplicate | IMG-ALT spot_img |
/solutions-to-identify-patient... | Subdomain Text duplicate | Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials A-TITLE Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials |
/author/kimberly_futch_001_bs-... | Subdomain Text duplicate | Kimberly Futch |
/crofelemer-reduces-diarrhea-i... | Subdomain Text duplicate | Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show A-TITLE Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show |
/author/okhuysen_pc-001/ | Subdomain Text duplicate | Pablo C. Okhuysen, M.D., FACP, FIDSA |
/study-shows-new-co-star-recep... | Subdomain Text duplicate | Study Shows New Co-Star Receptor to be Promising in Cancer Treatment A-TITLE Study Shows New Co-Star Receptor to be Promising in Cancer Treatment |
/author/peter-hofland/ | Subdomain Text duplicate | Peter Hofland |
/daiichi-sankyo-out-licenses-i... | Subdomain | Daiichi Sankyo Out-Licenses Investigational Agent DS-6051 to AnHeart Therapeutics A-TITLE Daiichi Sankyo Out-Licenses Investigational Agent DS-6051 to AnHeart Therapeutics |
/author/peter-hofland/ | Subdomain Text duplicate | Peter Hofland |
/how-meaningful-will-changes-b... | Subdomain | How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s Fall? A-TITLE How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s Fall? |
/author/erictrosenthal/ | Subdomain Text duplicate | Eric T. Rosenthal |
/reversal-of-fortune-how-a-vil... | Subdomain | Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’... A-TITLE Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer |
/author/peter-hofland/ | Subdomain Text duplicate | Peter Hofland |
/category/news/ | Subdomain | News2935 |
/category/conference-coverage/ | Subdomain | Conference Coverage507 |
/category/research-and-develop... | Subdomain | Research & Development364 |
/category/cancer-risk/ | Subdomain | Cancer Risk304 |
/category/clinical-trial-updates/ | Subdomain | Clinical Trial Updates277 |
/category/clinical-development/ | Subdomain | Clinical development271 |
/category/business-economics/ | Subdomain | Business & Economics197 |
/category/regulatory-updates/ | Subdomain | Regulatory Updates120 |
/category/op-ed-opinion/ | Subdomain | Op-Ed | Opinion112 |
/category/must-read-articles/ | Subdomain | Must Read Articles110 |
https://www.oncozine.com/ | Subdomain | IMG-ALT Onco\'Zine, The International Oncology Network |
https://www.facebook.com/oncoz... | New window External Subdomain Text duplicate | A-TITLE Facebook |
https://www.linkedin.com/showc... | New window External Subdomain Text duplicate | A-TITLE Linkedin |
https://soundcloud.com/hofrey | New window External Text duplicate | A-TITLE Soundcloud |
https://twitter.com/OncoZine | New window External Text duplicate | A-TITLE Twitter |
https://vimeo.com/channels/877242 | New window External Text duplicate | A-TITLE Vimeo |
https://www.youtube.com/channe... | New window External Subdomain Text duplicate | A-TITLE Youtube |
https://www.xing.com/communiti... | New window External Subdomain Text duplicate | A-TITLE Xing |
https://www.oncozine.com/ | Subdomain Text duplicate | Home |
/advertisement-sponsorship-opt... | Subdomain Text duplicate | Advertisement & Sponsorship Options |
https://lp.constantcontactpage... | External Subdomain Text duplicate | Download Our Media Kit |
/continued-medical-education-cme/ | Subdomain Text duplicate | Changing Physician Behavior |
/cancer-information-by-disease/ | Subdomain Text duplicate | Cancer A – Z |
http://www.oncozine.com/ | Subdomain Text duplicate | Drug Developmemt Technologies |
/a-novel-technology-based-on-s... | Subdomain Text duplicate | A Novel Technology based on Somatic Hypermutation (SHM) |
/about-oncozine/advisory-board-3/ | Subdomain Text duplicate | Editorial Advisory Board |
/join-our-editorial-advisory-b... | Subdomain Text duplicate | Join Our Editorial Advisory Board |
/contact-us/ | Subdomain Text duplicate | Contact Us |
/terms-and-conditions/ | Subdomain Text duplicate | Terms and Conditions |
/sabcs-and-ash-2023/ | Subdomain Text duplicate | SABCS and ASH 2023 |
http://www.adcreview.com/ | External Subdomain Text duplicate | ADC Review | J. Antibody-drug Conjugates |
https://www.adcreview.com/reso... | External Subdomain Text duplicate | Resources for For Clinicians |
https://www.adcreview.com/adc-... | External Subdomain Text duplicate | Drug Map (ADC) |
https://www.adcreview.com/cate... | External Subdomain Text duplicate | Peer Review Articles |
https://www.adcreview.com/the-... | External Subdomain Text duplicate | The Review |
/changing-strategies-in-the-wa... | Subdomain Text duplicate | Changing Strategies in the War on Cancer |
/changing-strategies-in-the-wa... | Subdomain Text duplicate | Changing Strategies in the War on Cancer – Episode 1 |
/changing-strategies-in-the-wa... | Subdomain Text duplicate | Changing Strategies in the War on Cancer – Episode 2 |
/changing-strategies-in-the-wa... | Subdomain Text duplicate | Changing Strategies in the War on Cancer – Episode 3 |
/centers-of-the-cancer-univers... | Subdomain Text duplicate | Centers of the Cancer Universe: A Half-Century of Progress Against Cancer |
http://cartcelljournal.com/ | External Text duplicate | Journal of CAR T-Cell Therapy |
http://cartcelljournal.com/about/ | External Text duplicate | About CAR T-cells |
http://cartcelljournal.com/faq/ | External Text duplicate | Frequently Asked Questions |
http://cartcelljournal.com/art... | External Text duplicate | Types of Articles |
http://cartcelljournal.com/for... | External Text duplicate | Submit a Manuscript |
/the_oncozine_brief_episodes/ | Subdomain Text duplicate | The Onco’Zine Brief |
/the_oncozine_brief_episodes/ | Subdomain Text duplicate | The Network |
/the-oncozine-brief-episodes/ | Subdomain Text duplicate | The Episodes |
https://www.patreon.com/theonc... | New window External Subdomain Text duplicate | How to Support The Onco’Zine Brief |
/underwriting/ | Subdomain Text duplicate | Corporate Underwriting and Sponsorship |
/the-oncozine-dossier/ | Subdomain Text duplicate | The Onco’Zine Dossier |
/thalidomide-a-history/ | Subdomain Text duplicate | Thalidomide: A History |
/thalidomide-in-the-shadow-of-... | Subdomain Text duplicate | Thalidomide: In the Shadow of Death |
/controversy-the-involvement-o... | Subdomain Text duplicate | Controversy: The involvement of Ciba AG in the development of Thalidomide |
/thalidomides-secret-past-the-... | Subdomain Text duplicate | Thalidomide’s Secret Past: The Link with Nazi Germany |
/reversal-of-fortune-how-a-vil... | Subdomain Text duplicate | Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer |
/oncozine-dossier-50-years-aft... | Subdomain Text duplicate | Smoking and Health |
/new-surgeon-generals-report-p... | Subdomain Text duplicate | New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco |
/smoking-and-the-lost-legacy-o... | Subdomain Text duplicate | Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health |
/tobacco-control-in-the-united... | Subdomain Text duplicate | Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years |
http://.com/tobacco-companies-... | External Text duplicate | Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking |
/the-harmful-effects-of-smokin... | Subdomain Text duplicate | The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s |
/oncozine.com/oncology-hematol... | Subdomain Text duplicate | Drug Approvals 2017 – 2020 |
/oncology-hematology-drug-appr... | Subdomain Text duplicate | Oncology & Hematology – FDA Drug Approvals 2018 |
/oncology-hematology-fda-drug-... | Subdomain Text duplicate | Oncology & Hematology – FDA Drug Approvals 2019 |
/oncology-hematology-fda-drug-... | Subdomain Text duplicate | Oncology & Hematology – FDA Drug Approvals 2020 |
/category/articles/ | Subdomain Text duplicate | Articles |
/category/latest-articles/ | Subdomain Text duplicate | Latest Articles |
/category/expert-interviews/ | Subdomain Text duplicate | Expert Interviews |
/category/editorial-and-commen... | Subdomain Text duplicate | Editorials and Commentaries |
/category/eric-rosenthal-reports/ | Subdomain Text duplicate | Eric Rosenthal Reports |
/category/publications-peer-re... | Subdomain Text duplicate | Publications |
/category/news/ | Subdomain Text duplicate | News |
/category/business-economics/ | Subdomain Text duplicate | Business & Economics |
/category/clinical-development/ | Subdomain Text duplicate | Clinical Development |
/category/conference-coverage/ | Subdomain Text duplicate | Conference Coverage |
/the_oncozine_brief_episodes/ | Subdomain Text duplicate | The Onco’Zine Brief |
/the-oncozine-brief-episodes/ | Subdomain Text duplicate | The Episodes |
/the-oncozine-brief-national-a... | Subdomain Text duplicate | National Advertising |
http://www.oncozine.com/ | New window Subdomain Text duplicate | Resources |
https://www.oncologydirectory.... | New window External Subdomain Text duplicate | Membership |
https://www.oncologydirectory.... | External Subdomain Text duplicate | Agenda |
https://www.oncologydirectory.... | New window External Subdomain Text duplicate | Join Today |
https://www.oncologydirectory.... | New window External Subdomain Text duplicate | Video |
/job-openings/ | Subdomain Text duplicate | Careers |
https://lp.constantcontactpage... | New window External Subdomain | No Text |
Name | Value |
---|---|
server | nginx |
date | Sun, 14 Jul 2024 05:25:10 GMT |
content-type | text/html; charset=UTF-8 |
vary | Accept-Encoding |
x-cache-enabled | True |
link | <https://www.oncozine.com/wp-json/>; rel="https://api.w.org/", <https://www.oncozine.com/wp-json/wp/v2/pages/6893>; rel="alternate"; type="application/json", <https://www.oncozine.com/>; rel=shortlink |
x-httpd | 1 |
x-cdn-c | all |
content-encoding | gzip |
x-sg-cdn | 1 |
x-proxy-cache | HIT |
host-header | 8441280b0c35cbc1147f8ba998a563a7 |
statuscode | 200 |
http_version | HTTP/2 |
# START WPFORMS BLOCK # --------------------------- User-agent: * Disallow: /wp-content/uploads/wpforms/ # --------------------------- # END WPFORMS BLOCK # START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://www.oncozine.com/sitemap_index.xml # --------------------------- # END YOAST BLOCK
Following keywords were found. You can check the keyword optimization of this page for each keyword.
Keyword | Result | Recheck |
---|---|---|
Onco | 95% | Check |
Onco Zine | 94% | Check |
Zine | 91% | Check |
Oncology | 80% | Check |
Oncology Network | 78% | Check |
Network | 76% | Check |
Onco Zine Brief | 75% | Check |
Oncology Hematology | 69% | Check |
News Network | 69% | Check |
Hematology News Network | 65% | Check |
News | 61% | Check |
Oncology Informatics | 61% | Check |
Oncology Hematology FDA | 57% | Check |
Cancer | 56% | Check |
Hematology | 56% | Check |
Cancer Patients | 55% | Check |
Patients | 54% | Check |
inform | 54% | Check |
Oncology Hematology FDA Drug | 52% | Check |
Better | 51% | Check |
Cancer Treatment | 49% | Check |
Breast Cancer | 49% | Check |
Cancer Health | 49% | Check |
Kidney Cancer | 49% | Check |
Cancer Episode | 47% | Check |
Please select one of the following options for your request.
Contact options
Send us an email at [email protected]
Give us a call +49 911 23756261
Mo-Fr (CET)
from 9 am to 5 pm
None of these options suit your need?
You can also download our Quick Start Guide, visit the FAQ section, our Knowledge Base or Blog.
Please select one of the following options for your request.
We have received your message and will process it as soon as possible.
We use cookies to make our site work and also for analytics and advertising purposes. You can enable or disable optional cookies as desired. See the following links for more information.
We need these so the site can function properly
So we can better understand how visitors use our website
So we can serve you tailored ads and promotions
(Nice to have)